We would like to invite you to this webinar, which will take place on October 29, 2024. We are organizing this event together with our partners SCIREQ and 3RsC.
"Maximizing drug development efficiency using predictive in vitro and ex vivo models"
Speaker: Dr. Katharina Schwarz
More information
The webinar deals with innovative strategies for enhancing drug development efficiency using predictive in vitro and ex vivo models. It focuses on the approach developed by the Fraunhofer ITEM, which streamlines drug development by offering faster, cost-effective, and predictive methods for developing new inhalable therapeutics.
Key highlights
You can register on the here. Participation is free of charge.
Virtual (Zoom)
October 29, 2024, 10–11 a.m.
English
Dr. Katharina Schwarz leads the department "Inhalation and Aerosol Research" at the Fraunhofer ITEM.
She is an expert at the interface between aerosol/inhalation research, respiratory pharmacokinetics, toxicology/physiology, and inhalation exposure science with a special focus on particle lung dosimetry and biophysical particle-lung interactions. In her institutional role she is responsible for the aerosol aerosol/inhalation and dosimetry-related/QIVIVE-related aspects in drug development programs as well as toxicological and inhalation exposure studies including GLP/GCP-compliance.
Fraunhofer Institute for Toxicology and Experimental Medicine